Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05930925 · ClinicalTrials.gov registry record · Phase 1
A Study to Understand How the Study Medicine Called ARV-471 is Processed in Healthy Adults
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT05930925 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 12 participants.
The verdict
NCT05930925, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of the study is to understand how the study medicine ARV-471 is processed in the body of healthy males and females who do not have the potential to have children. This study is seeking for participants who: * are healthy males and females who do not have the potential to have children. * are 18 years of age or older. * weigh more than 110 pounds.
Interventions
- DRUG [phenyl-14C]ARV-471
- DRUG [oxoisoindolin-14C]ARV-471
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2023-06-12 |
| Est. Completion | 2023-08-14 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05930925
The ClinicalTrials.gov registry entry for NCT05930925 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which [phenyl-14C]ARV-471 is the first listed.
NCT05930925 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05930925 about?
NCT05930925 is a clinical study titled "A Study to Understand How the Study Medicine Called ARV-471 is Processed in Healthy Adults". The purpose of the study is to understand how the study medicine ARV-471 is processed in the body of healthy males and females who do not have the potential to have children. This study is seeking for participants who: * are healthy males and females who do not have the potential to have children....
What is the current status of trial NCT05930925?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2023-06-12. Estimated completion is 2023-08-14.
What interventions are being tested in trial NCT05930925?
The interventions under investigation include: [phenyl-14C]ARV-471 (DRUG), [oxoisoindolin-14C]ARV-471 (DRUG).
Who is sponsoring clinical trial NCT05930925?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.